Guglielmo Riccardo, Martinotti Giovanni, Janiri Luigi
Department of Neuroscience, Institute of Psychiatry, Catholic University of Rome, Rome, Italy.
Clin Neuropharmacol. 2012 Jan-Feb;35(1):45-6. doi: 10.1097/WNF.0b013e31823e669b.
Somatoform disorder is a relatively common and severe disorder for which pharmacotherapy has been minimally studied. We report a case of 30-year-old woman with treatment-resistant somatoform disorder that was successfully treated with add-on treatment of gabapentin. Our result showed that gabapentin 1800 mg/day could be tried in case of treatment-resistant somatoform disorder as an add-on strategy. However, controlled trials are needed to investigate the effectiveness of gabapentin in the management of this condition.
躯体形式障碍是一种相对常见且严重的疾病，针对该疾病的药物治疗研究极少。我们报告了一例30岁患有难治性躯体形式障碍的女性患者，通过加用加巴喷丁成功治愈。我们的结果表明，对于难治性躯体形式障碍患者，可尝试每日1800毫克加巴喷丁作为一种附加治疗策略。然而，需要进行对照试验来研究加巴喷丁在治疗这种疾病中的有效性。
